Trial for the Prevention of Depression (TriPoD) in final-year secondary students: Study protocol for a cluster randomised controlled trial
journal contributionposted on 22.07.2020, 01:31 by Y Perry, AL Calear, A Mackinnon, PJ Batterham, J Licinio, C King, N Thomsen, J Scott, T Donker, S Merry, Theresa Fleming, K Stasiak, A Werner-Seidler, H Christensen
© 2015 Perry et al. Background: Evidence suggests that current treatments cannot fully alleviate the burden of disease associated with depression but that prevention approaches offer a promising opportunity to further reduce this burden. Adolescence is a critical period in the development of mental illness, and final school examinations are a significant and nearly universal stressor that may act as a trigger for mental health difficulties such as depression. The aim of the present trial is to investigate the impact of SPARX-R, an online, gamified intervention based on cognitive behavioural principles, on the prevention of depression in secondary school students before their final examinations. Methods/Design: Government, independent and Catholic secondary schools in New South Wales, Australia, will be recruited to participate in the trial. All students enrolled in their final year of high school (year 12) in participating schools will be invited to participate. To account for possible attrition, the target sample size was set at 1600 participants across 30 schools. Participating schools will be cluster randomised at the school level to receive either SPARX-R or lifeSTYLE, an attention-controlled placebo comparator. The control intervention is an online program aimed at maintaining a healthy lifestyle. The primary outcome will be symptoms of depression, and secondary outcomes will include symptoms of anxiety, suicidal ideation and behaviours, stigma and academic performance. Additional measures of cost-effectiveness, as well as process variables (e.g., adherence, acceptability) and potential predictors of response to treatment, will be collected. Consenting parents will be invited to complete measures regarding their own mental health and expectations for their child. Assessments will be conducted pre- and post-intervention and at 6- and 18-month follow-up. Primary analyses will compare changes in levels of depressive symptomatology for the intervention group relative to the attention control condition using mixed-effects model repeated-measures analyses to account for clustering within schools. Discussion: This is the first trial of a universal depression prevention intervention delivered to school students in advance of a specific, significant stressor. If found to be effective, this program may offer schools a new approach to preparing students for their final year of schooling. Trial registration: Australian New Zealand Clinical Trials Registry identifier: ACTRN12614000316606. Registered 25 March 2014.
Preferred citationPerry, Y., Calear, A.L., Mackinnon, A., Batterham, P.J., Licinio, J., King, C., Thomsen, N., Scott, J., Donker, T., Merry, S.N., Fleming, T., Stasiak, K., Seidler, A.W. & Christensen, H. (2015). Trial for the Prevention of Depression (TriPoD) in final-year secondary students: Study protocol for a cluster randomised controlled trial. Trials, 16(451), 1-17. https://doi.org/10.1186/s13063-015-0929-1
PublisherSpringer Science and Business Media LLC
Online publication date12/10/2015
Read the peer-reviewed publication
AdolescentsCBTComputerised CBTDepressioneHealthPreventionRCTSchoolClinicalPublic HealthMental HealthClinical ResearchPediatricClinical Trials and Supportive ActivitiesBehavioral and Social ScienceMind and Body3.1 Primary prevention interventions to modify behaviours or promote well-being6.6 Psychological and behaviouralAdolescentAdolescent BehaviorAge FactorsCognitive Behavioral TherapyEducational MeasurementEducational StatusFemaleHumansMaleMental Health ServicesNew South WalesPsychiatric Status Rating ScalesResearch DesignRisk FactorsSchool Health ServicesStudentsTherapy, Computer-AssistedTime FactorsCognitive TherapyScience & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalResearch & Experimental MedicineINSOMNIA SEVERITY INDEXRISK BEHAVIOR SURVEYOF-LIFE AQOLMENTAL-HEALTHMAJOR DEPRESSIONPSYCHOMETRIC PROPERTIESADOLESCENT DEPRESSIONMAINTENANCE THERAPIESCONSTRUCT-VALIDITYSUICIDAL-BEHAVIORGeneral & Internal MedicineCardiovascular System & HematologyPublic Health and Health ServicesPsychologyClinical SciencesCardiorespiratory Medicine and Haematology